A. Hoeben

Padovan, B. V., van der Velden, L. A., Hardillo, J. A. U., van Egmond, S. L., Hoeben, A., Eerenstein, S. E. J., Schoon, Y., de Bree, R., de Kleijn, B. J., van Bemmel, A. J. M., Sedee, R. J., Vesseur, A., Plaat, R. E., Festen, S., & Halmos, G. B. (2025). Clinical practice variations in geriatric assessment for patients with head and neck cancer in the Netherlands: A nationwide analysis. Journal of Geriatric Oncology, 16(8), Article 102715. https://doi.org/10.1016/j.jgo.2025.102715

Jacquerie, A., Macamo, A., Hoeben, A., Eekers, D., Postma - Jacobi, L., Vanmechelen, M., Ackermans, L., Anten, M. H. M. E., Verduin, M., Severens - Rijvers, C., zur Hausen, A., Beckervordersandforth, J., & Broen, M. (2025). IDO2-AhR axis as central regulator of the kynurenine pathway in glioblastoma. Journal of Neuro-Oncology, 174(3), 721-731. https://doi.org/10.1007/s11060-025-05106-w

Fayette, J., Licitra, L., Harrington, K., Haddad, R., Siu, L. L., Liu, Y.-C., Tahara, M., Machiels, J.-P., Rischin, D., Seiwert, T. Y., Ferris, R. L., Keilholz, U., Psyrri, A., Keam, B., Bossi, P., Metcalf, R., Hsieh, C.-Y., Clement, P. M. J., Isaev, P., ... Cohen, R. B. (2025). INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab Plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research, 31(13), 2617-2627. https://doi.org/10.1158/1078-0432.CCR-25-0073

Hamulyák, E. N., Wang, T.-F., Kreuziger, L. B., Iyengar, V., Carney, B. J., Hoeben, A., Özdemir, B. C., Serrano, R. D. C., Sanfilippo, K. M., Rozenblatt, S., Beenen, L. F. M., Yust-Katz, S., Halperin, E., Arad, A., Lubetsky, A., Carrier, M., Massat, B., Büller, H. R., Spectre, G., ... ten Cate, H. (2025). Multinational cohort study of intracranial hemorrhage in patients with brain metastases receiving anticoagulation. Haematologica-the Hematology Journal, 110(6), 1417-1421. https://doi.org/10.3324/haematol.2024.286973

Huang, S. H., Su, J., Koyfman, S. A., Routman, D., Hoebers, F., Bahig, H., Yu, E., Bartlett, E., Spreafico, A., Lee, J., Stock, S., Davis, R., Woody, N. M., Nelson, K., Lavigne, D., Nguyen-Tan, P. F., Létourneau-Guillon, L., Filion, E., Nagelschneider, A. A., ... O'Sullivan, B. (2025). A Proposal for HPV-Associated Oropharyngeal Carcinoma in the Ninth Edition Clinical TNM Classification. JAMA Otolaryngology - Head and Neck Surgery. Advance online publication. https://doi.org/10.1001/jamaoto.2025.0848

Vaassen, F., Hofstede, D., Zegers, C. M. L., Dijkstra, J. B., Hoeben, A., Anten, M. H. M. E., Houben, R. M. A., Hoebers, F., Compter, I., van Elmpt, W., & Eekers, D. B. P. (2025). The effect of radiation dose to the brain on early self-reported cognitive function in brain and head-and-neck cancer patients. Clinical and Translational Radiation Oncology, 52, Article 100929. https://doi.org/10.1016/j.ctro.2025.100929

Verhees, F., Demers, I., Legemaate, D., Jacobs, R., Hoeben, A., Kremer, B., & Speel, E.-J. (2025). Exploring the antiproliferative effect of PI3K/Akt/mTOR pathway and CDK4/6 inhibitors in human papillomavirus-positive and -negative head and neck squamous cell carcinoma cell lines. International Journal of Oncology, 66(2), Article 13. https://doi.org/10.3892/ijo.2025.5719

de Leeuw, A. L. M. P., Giralt, J., Tao, Y., Benavente, S., Nguyen, T.-V. F., Hoebers, F. J. P., Hoeben, A., Terhaard, C. H. J., Lee, L. W., Friesland, S., Steenbakkers, R. J. H. M., Tans, L., van Kranen, S. R., van de Kamer, J. B., Bartelink, H., Rasch, C. R. N., Sonke, J.-J., & Hamming-Vrieze, O. (2025). Protocol compliance in a multicentric phase III trial investigating scheduled adaptive radiotherapy and dose painting in head and neck cancer. Radiotherapy and Oncology, 202, Article 110612. https://doi.org/10.1016/j.radonc.2024.110612

Florie, M. G. M. H., Wieland, M. W. M., Pilz, W., Partoens, R., Winkens, B., Hoeben, A., Rommel, N., & Baijens, L. W. J. (2025). Prevalence and Risk Factors of Oropharyngeal Dysphagia in Newly Diagnosed Head-and-Neck Cancer Patients. Cancers, 17(1), Article 9. https://doi.org/10.3390/cancers17010009

Verkerk, K., van der Wel, T. J. W. T., Zeverijn, L. J., Geurts, B. S., Spiekman, I. A. C., de Wit, G. F., Roepman, P., Jansen, A. M. L., van der Noort, V., Smit, E. F., Hoeben, A., Hendriks, L. E. L., Van den Heuvel, M. M., Piet, B., Herder, G. J. M., Hashemi, S. M. S., Gelderblom, H., Verheul, H. M. W., Voest, E. E., & de Langen, A. J. (2024). Safety, Efficacy and Biomarker Analysis of Crizotinib in MET Mutated Non-Small Cell Lung Cancer - Results from the Drug Rediscovery Protocol. Clinical Cancer Research, 30(23), 5323-5332. https://doi.org/10.1158/1078-0432.CCR-24-1925